PS
CNST

Peter Svennilson’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Peter Svennilson’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$123M Hold
6,051,376
– – 10% 5
2020
Q2 		$182M Hold
6,051,376
– – 15.21% 4
2020
Q1 		$190M Buy
6,051,376
+41,674
+0.7% +$1.45M 24.08% 2
2019
Q4 		$283M Hold
6,009,702
– – 33.81% 2
2019
Q3 		$38.8M Buy
6,009,702
+1,331,763
+28% +$11.1M 12.07% 2
2019
Q2 		$57.4M Hold
4,677,939
– – 16.42% 2
2019
Q1 		$63.4M Buy
4,677,939
+1
+0% +$9 33.76% 1
2018
Q4 		$18.8M Buy
+4,677,938
New +$28.2M 16.53% 3

Other funds holding CNST

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMV
Venrock Management V Palo Alto, California $719M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Peter Svennilson's CNST Position: Q3 2020 in Review

Peter Svennilson held its Constellation Pharmaceuticals, Inc. (CNST) position steady in Q3 2020 at 6,051,376 shares worth $123M. The position accounts for 10% of the portfolio, ranked #5.

Peter Svennilson first reported a position in CNST in Q4 2018 and has held it in 8 quarters since. The position peaked at $283M in Q4 2019. 119 funds tracked by Wall St. Rank hold CNST as of Q3 2020.

  • Peter Svennilson held 6,051,376 shares of Constellation Pharmaceuticals, Inc. worth $123M as of Q3 2020.
  • Peter Svennilson left its Constellation Pharmaceuticals, Inc. share count unchanged in Q3 2020.
  • Constellation Pharmaceuticals, Inc. made up 10% of Peter Svennilson's portfolio in Q3 2020, its #5 holding.
  • Peter Svennilson first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2018 and has held it in 8 quarters since.
  • Peter Svennilson's Constellation Pharmaceuticals, Inc. position peaked at $283M in Q4 2019.
  • 119 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2020.

Based on Peter Svennilson's 13F filing for Q3 2020, filed 4 Nov 2020.